PUR-1800

N/A

Report date: 2024/07/11 09:52:38
NME

Base Information

Drug NamePUR-1800
Drug Alias NamePUR-1800RV-1162
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRespivert Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPulmatrix Inc
Inactive CompaniesRespivert Ltd
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A